Clinical trials: Vasodilatory Shock, open to volunteers
- Condition Vasodilatory Shock
- Status Open to volunteers
- Funder type Industry (pharma, biotech, devices)
Vasodilatory Shock
Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock
A randomized, double-blind, placebo-controlled study on the treatment of refractory distributed shock with angiotensin II injection, with a random ratio of 1:1.
- Trial name
- NCT06351150
- Testing
- Angiotensin II Injection, 0.9% sodium chloride injection
- Where
- 42 sites in China
- Volunteers
- 214 people
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.